W. Zheng, “A humanized anti-Toll like receptor 4 antibody Fab fragment inhibits pro-inflammatory responses induced by lipopolysaccharide through TLR4 in vitro and in vivo”, J Infect Dev Ctries, vol. 19, no. 06, pp. 913–923, Jun. 2025.